These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 14714041

  • 1. [An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].
    Rørtveit S, Rørtveit G.
    Tidsskr Nor Laegeforen; 2003 Sep 25; 123(18):2557-60. PubMed ID: 14714041
    [Abstract] [Full Text] [Related]

  • 2. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
    Rørtveit S, Skutlaberg DH, Langeland N, Rortveit G.
    J Antimicrob Chemother; 2011 Jun 25; 66(6):1360-4. PubMed ID: 21393202
    [Abstract] [Full Text] [Related]

  • 3. Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.
    Rørtveit S, Rortveit G.
    Br J Dermatol; 2007 Jul 25; 157(1):100-5. PubMed ID: 17553056
    [Abstract] [Full Text] [Related]

  • 4. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
    Rørtveit S, Skutlaberg DH, Langeland N, Rortveit G.
    Scand J Infect Dis; 2014 Dec 25; 46(12):832-7. PubMed ID: 25229166
    [Abstract] [Full Text] [Related]

  • 5. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
    Alsterholm M, Flytström I, Bergbrant IM, Faergemann J.
    Acta Derm Venereol; 2010 Dec 25; 90(1):52-7. PubMed ID: 20107726
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Impetigo bullosa].
    Tveten Y.
    Tidsskr Nor Laegeforen; 2003 Nov 06; 123(21):3089; author reply 3089. PubMed ID: 14618190
    [No Abstract] [Full Text] [Related]

  • 8. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
    Laurent F, Tristan A, Croze M, Bes M, Meugnier H, Lina G, Vandenesch F, Etienne J.
    J Antimicrob Chemother; 2009 Feb 06; 63(2):420-1; author reply 421. PubMed ID: 18978362
    [No Abstract] [Full Text] [Related]

  • 9. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P, Jarlier V, Santerre-Henriksen A.
    Ann Dermatol Venereol; 2008 Jan 06; 135(1):13-9. PubMed ID: 18342068
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Liu Y, Kong F, Zhang X, Brown M, Ma L, Yang Y.
    Br J Dermatol; 2009 Dec 06; 161(6):1347-50. PubMed ID: 19754868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study].
    Couppié P, Sainte-Marie D, Prévost G, Gravet A, Clyti E, Moreau B, Monteil H, Pradinaud R.
    Ann Dermatol Venereol; 1998 Oct 06; 125(10):688-93. PubMed ID: 9835957
    [Abstract] [Full Text] [Related]

  • 13. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
    Osterlund A, Kahlmeter G, Haeggman S, Olsson-Liljequist B, Swedish Study Group On Fusidic Acid Resistant S Aureus.
    Scand J Infect Dis; 2006 Oct 06; 38(5):334-4. PubMed ID: 16724423
    [Abstract] [Full Text] [Related]

  • 14. Fusidic acid cream for impetigo. Findings cannot be extrapolated.
    Owen SE, Cheesbrough JS.
    BMJ; 2002 Jun 08; 324(7350):1394. PubMed ID: 12053931
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant Staphylococcus aureus with additional resistance to fusidic acid, June 2018 to January 2020.
    Vendrik KEW, Kuijper EJ, Dimmendaal M, Silvis W, Denie-Verhaegh E, de Boer A, Postma B, Schoffelen AF, Ruijs WLM, Koene FMHPA, Petrignani M, Hooiveld M, Witteveen S, Schouls LM, Notermans DW, MRSA consortiumThe members of the MRSA consortium are listed under Collaborators..
    Euro Surveill; 2022 Dec 08; 27(49):. PubMed ID: 36695440
    [Abstract] [Full Text] [Related]

  • 17. Fusidic acid cream for impetigo. Problem may be clinically important.
    Stoddart B, Collyns T, Denton M.
    BMJ; 2002 Jun 08; 324(7350):1394. PubMed ID: 12053929
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
    Vogel A, Lennon D, Best E, Leversha A.
    N Z Med J; 2016 Oct 14; 129(1443):77-83. PubMed ID: 27736855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.